From Prescription to Personalization: An HCP’s Guide to Tailoring MS Therapeutic Management

Dr. Mark S. Freedman of Ottawa Hospital Research Institute outlines how we can tailor MS therapeutic management to MS patients.
This video is part of a larger CE/CME Certified program entitled: Multiple Sclerosis: Using S1P Receptor Modulators to Slow Disease Progression. You can receive free CME credit, view this video, and download slides from the presentation at www.mededonthego.com/Video/pr...